نتایج جستجو برای: neoadjuvant chemotherapy

تعداد نتایج: 120769  

Journal: :Chinese journal of cancer 2010
Jia-Hao Wu Jing-Song He Yong Ni Xian-Ming Wang

With the widespread clinical application of neoadjuvant chemotherapy, it has become an essential part of combination therapy for patients with breast cancer. However, a rapid, accurate, and effective approach for assessing the therapeutic efficacy of neoadjuvant chemotherapy is unavailable. Routine physical examinations cannot provide effective clinical evaluation. Although imaging techniques p...

2017
Bikram Shrestha Yifei Sun Farzana Faisal Victoria Kim Kevin Soares Alex Blair Joseph M Herman Amol Narang Avani S Dholakia Lauren Rosati Amy Hacker-Prietz Linda Chen Daniel A Laheru Ana De Jesus-Acosta Dung T Le Ross Donehower Nilofar Azad Luis A Diaz Adrian Murphy Valerie Lee Elliot K Fishman Ralph H Hruban Tingbo Liang John L Cameron Martin Makary Matthew J Weiss Nita Ahuja Jin He Christopher L Wolfgang Chiung-Yu Huang Lei Zheng

The use of neoadjuvant chemotherapy or radiation for borderline resectable pancreatic adenocarcinoma (BL-PDAC) is increasing. However, the impact of neoadjuvant chemotherapy and radiation therapy on the outcome of BL-PDAC remains to be elucidated. We performed a retrospective analysis of 93 consecutive patients who were diagnosed with BL-PDAC and primarily followed at Johns Hopkins Hospital bet...

2013
Shunichiro Nomura Yasutomo Suzuki Ryo Takahashi Mika Terasaki Ryoji Kimata Tsutomu Hamasaki Go Kimura Akira Shimizu Yukihiro Kondo

BACKGROUND Neoadjuvant chemotherapy has been shown to have benefit in T1 high-grade or T2 bladder cancer. However, neoadjuvant chemotherapy fails in some patients. Careful patient selection for neoadjuvant chemotherapy is therefore needed. Several reports show that Snail is associated with resistance to chemotherapy. We hypothesized that Snail expression could predict survival in T1 high-grade ...

2012
Prapaporn Suprasert

Neoadjuvant chemotherapy is introduced in many gynecologic cancers such as cervical and ovarian cancer. The aim of using neoadjuvant chemotherapy is to reduce the tumor size prior to the principle treatment, either radiation or surgery. The benefit of reducing tumor size can increase the operability and decrease the morbidity in many types of gynecologic cancers. Besides this, neoadjuvant chemo...

Journal: :European journal of cancer 1991
Marjorie Green Gabriel N Hortobagyi

Adjuvant systemic chemotherapy has been shown to prolong survival in all subsets of patients with breast cancer. In addition, among patients with locally advanced breast cancer, neoadjuvant orpreoperative chemotherapy has improved the ability to perform breast-conserving therapy. This observation, combined with multiple preclinical hypotheses and the results of laboratory studies, has prompted ...

Journal: :The Lancet. Oncology 2013
Thorsten Kuehn Ingo Bauerfeind Tanja Fehm Barbara Fleige Maik Hausschild Gisela Helms Annette Lebeau Cornelia Liedtke Gunter von Minckwitz Valentina Nekljudova Sabine Schmatloch Peter Schrenk Annette Staebler Michael Untch

BACKGROUND The optimum timing of sentinel-lymph-node biopsy for breast cancer patients treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) study was designed to evaluate a specific algorithm for timing of a standardised sentinel-lymph-node biopsy procedure in patients who undergo neoadjuvant chemotherapy. METHODS SENTINA is a four-arm, prospective, multicent...

2016
Gi Won Shin Young Mi Park Hye Kyoung Yoon Soo Jin Jung Tae Hyun Kim Anbok Lee Seok Mo Lee

In patients with advanced breast cancer, most new calcifications detected on a mammogram after neoadjuvant chemotherapy are benign dystrophic calcifications, but this is not always observed. We present a patient with advanced breast cancer who had paradoxically increased malignant microcalcifications concomitant with primary tumor regression after undergoing neoadjuvant chemotherapy. After the ...

Journal: :Gan to kagaku ryoho. Cancer & chemotherapy 2007
Naoto Miyanaga Hideyuki Akaza

Radical cystectomy is the standard treatment for patients with muscle-invasive bladder cancer. Bladder cancer is a chemoresponsive disease and should be dealt with in a multimodality approach. Neoadjuvant chemotherapy is intended for patients with operable clinical stage T2 to T4a muscle-invasive disease to improve survival. Meta-analysis of cisplatin-containing combination neoadjuvant chemothe...

2015
Daofu Feng Meiha Leong Ting Li Lin Chen Tao Li

BACKGROUND We wished to evaluate the impact of S-1 combined with oxaliplatin (SOX regimen) as neoadjuvant chemotherapy on surgical outcomes after gastrectomy with D2 lymphadenectomy. METHODS From February 2012 to September 2013, 170 patients with American Joint Committee on Cancer (AJCC) stage II-III gastric cancer were assessed retrospectively. Eighty patients underwent neoadjuvant chemother...

2017
Opal L Reddy Sophia K Apple

Chemotherapy and hormonal treatment decisions for breast cancer are influenced by the expression of tumor biomarkers, including estrogen receptor, progesterone receptor and human epidermal growth hormone receptor 2 (HER2/neu). These biomarkers are most commonly assessed by immunohistochemical staining and fluorescence in situ hybridization studies performed on breast cancer biopsy specimens. Bi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید